Brad Bryan, Ph.D., Texas Tech University Health Sciences Center El Paso (1 of 2) (IMAGE)

Texas Tech University Health Sciences Center El Paso

Brad Bryan, Ph.D., Texas Tech University Health Sciences Center El Paso (1 of 2)

Caption

Brad Bryan, Ph.D., is studying how the common heart drug propranolol may stop the progression of angiosarcoma, a highly lethal cancer of the blood vessels.

Credit

Texas Tech University Health Sciences Center El Paso

Usage Restrictions

Credit Required.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.